Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRILOGY: Beclometasone + Formoterol + Glycopyrrolate vs Foster in COPD
NCT01917331Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Mar 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Mar 2014; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01917331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917331.